AR078485A1 - Bifidobacterium longum atcc baa-999 (bl999) y control de peso - Google Patents
Bifidobacterium longum atcc baa-999 (bl999) y control de pesoInfo
- Publication number
- AR078485A1 AR078485A1 ARP100103572A ARP100103572A AR078485A1 AR 078485 A1 AR078485 A1 AR 078485A1 AR P100103572 A ARP100103572 A AR P100103572A AR P100103572 A ARP100103572 A AR P100103572A AR 078485 A1 AR078485 A1 AR 078485A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition according
- composition
- atcc baa
- weight control
- bifidobacterium longum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Uso de Bifidobacterium Iongum ATCC BAA-999 para ayudar al control del peso, promover la perdida de peso y/o para tratar la obesidad. Reivindicacion 2. Composicion de acuerdo con la reivindicacion 1, en donde los humanos o los animales presentan sobrepeso o son obesos. Reivindicacion 3: Composicion de acuerdo con una de las reivindicaciones anteriores, en donde los humanos tienen al menos 16 anos de edad y de preferencia son adultos. Reivindicacion 4: Composicion de acuerdo con una de las reivindicaciones anteriores, en donde la composicion es una composicion farmacéutica, una bebida o un producto alimenticio. Reivindicacion 6: Composicion de acuerdo con la reivindicacion 5, caracterizada porque las bacterias de grado alimentario se seleccionan del grupo que consiste de bacteria de ácido láctico, bifidobacteria, propionibacteria o mezclas de las mismas. Reivindicacion 8: Composicion de acuerdo con la reivindicacion 6 caracterizada porque el prebiotico es seleccionado del grupo que consiste de oligosacáridos y opcionalmente contiene fructosa, galactosa, manosa, soja y/o inulina; fibras dietarias; o mezclas de las mismas. Reivindicacion 9: Composicion de acuerdo con una de las reivindicaciones anteriores, en donde al menos algunas de las Bifidobacterium Iongum ATCC BAA-999 están vivas en la composicion. Reivindicacion 10: Composicion de acuerdo con una de las reivindicaciones anteriores, en donde al menos algunas de las Bifidobacterium Iongum ATCC BAA-999 no están vivas en la composicion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09171866A EP2308499A1 (en) | 2009-09-30 | 2009-09-30 | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
Publications (1)
Publication Number | Publication Date |
---|---|
AR078485A1 true AR078485A1 (es) | 2011-11-09 |
Family
ID=41683555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103572A AR078485A1 (es) | 2009-09-30 | 2010-09-30 | Bifidobacterium longum atcc baa-999 (bl999) y control de peso |
Country Status (14)
Country | Link |
---|---|
US (1) | US20120244125A1 (es) |
EP (2) | EP2308499A1 (es) |
JP (1) | JP5911424B2 (es) |
CN (1) | CN102665737A (es) |
AR (1) | AR078485A1 (es) |
AU (1) | AU2010303020B2 (es) |
BR (1) | BR112012007109A2 (es) |
CA (1) | CA2775976A1 (es) |
CL (1) | CL2012000809A1 (es) |
IN (1) | IN2012DN02463A (es) |
MX (1) | MX2012003612A (es) |
RU (1) | RU2567660C2 (es) |
SG (1) | SG10201406169VA (es) |
WO (1) | WO2011039176A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109069553A (zh) * | 2016-04-14 | 2018-12-21 | 杜邦营养生物科学有限公司 | 用于增加瘦体重的双歧杆菌 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5615285B2 (ja) * | 2010-03-18 | 2014-10-29 | 森永乳業株式会社 | 貧血の予防又は治療用組成物 |
EP2452575A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Array of age-tailored nutritional formula with probiotics |
FI20116008A0 (fi) * | 2011-10-12 | 2011-10-12 | Maeyrae Maekinen Annika | Viskeraalisen rasvan estäminen ja diagnostisointi |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
CN108271917A (zh) | 2013-03-08 | 2018-07-13 | 艾斯姆食品公司 | 大米蛋白补充剂 |
JP6234331B2 (ja) * | 2014-06-13 | 2017-11-22 | 森永乳業株式会社 | 統合失調症治療剤 |
TWI572713B (zh) * | 2014-10-31 | 2017-03-01 | 豐華生物科技股份有限公司 | 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用 |
JP6650728B2 (ja) * | 2015-03-06 | 2020-02-19 | 株式会社ファンケル | ダイエット用の製剤 |
EP3386523B1 (en) * | 2015-12-11 | 2019-10-09 | Alimentary Health Limited | Bifidobacterium longum for treating obesity and associated metabolic disorders |
JP6847577B2 (ja) * | 2015-12-28 | 2021-03-24 | 森永乳業株式会社 | ビフィドバクテリウム属細菌および/または乳酸菌の増殖促進および/または減少抑制剤 |
IT201600105831A1 (it) * | 2016-10-20 | 2018-04-20 | Probiotical Spa | Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo |
KR101920219B1 (ko) * | 2017-03-08 | 2018-11-20 | 서울대학교산학협력단 | 비피더스균을 포함하는 비만 예방 또는 개선용 조성물 |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
EP3673044A1 (en) | 2017-08-25 | 2020-07-01 | University College Cork-National University of Ireland, Cork | Bifidobacterium longum for treating obesity and weight management |
AU2017438436B2 (en) * | 2017-10-31 | 2022-01-13 | Morinaga Milk Industry Co., Ltd. | Muscle-building composition |
WO2019102018A2 (en) | 2017-11-24 | 2019-05-31 | University College Cork, National University Of Ireland, Cork | A composition comprising a cohort of bacteria |
CN112672749B (zh) * | 2018-04-11 | 2024-07-23 | 韩国生命工学研究院 | 具有肥胖预防或治疗效果的新的长双歧杆菌菌株或鼠李糖乳杆菌菌株及其用途 |
CN111187734A (zh) * | 2019-12-25 | 2020-05-22 | 生合生物科技(扬州)有限公司 | 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用 |
JP7475155B2 (ja) * | 2020-02-14 | 2024-04-26 | 森永乳業株式会社 | 持久力向上用組成物 |
EP4070670A1 (en) | 2021-04-08 | 2022-10-12 | University College Cork-National University of Ireland Cork | Lacticaseibacillus paracasei em025-11 and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61109729A (ja) * | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
JP2687229B2 (ja) * | 1988-11-11 | 1997-12-08 | 株式会社ヤクルト本社 | 血圧降下剤 |
JP4280016B2 (ja) * | 2002-02-28 | 2009-06-17 | 雪印乳業株式会社 | 糖尿病合併症予防・改善・治療剤 |
JP2003252771A (ja) * | 2002-03-04 | 2003-09-10 | Snow Brand Milk Prod Co Ltd | 加齢に伴う代謝異常疾患の予防・改善・治療剤 |
SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
JP2007169200A (ja) * | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
PL1981516T3 (pl) * | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
RU2445362C2 (ru) * | 2006-02-15 | 2012-03-20 | Нестек С.А. | Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего |
US20090170772A1 (en) * | 2006-03-31 | 2009-07-02 | Morinaga Milk Industry Co., Ltd. | Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
KR20080075971A (ko) * | 2007-02-14 | 2008-08-20 | (주)네오팜 | 프로바이오틱스 복합 제제 |
EP1974734A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
EP2022502A1 (en) * | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
UA30077U (uk) * | 2007-10-18 | 2008-02-11 | Одесская Национальная Академия Пищевых Технологий | Композиція для йогурту діабетичного призначення |
UA31009U (uk) * | 2007-10-18 | 2008-03-25 | Одесская Национальная Академия Пищевых Технологий | Кисломолочний напій діабетичного призначення |
JP2009143820A (ja) * | 2007-12-12 | 2009-07-02 | Tsujido Chemical Corp | 高尿酸血症の予防または改善剤 |
-
2009
- 2009-09-30 EP EP09171866A patent/EP2308499A1/en not_active Withdrawn
-
2010
- 2010-09-28 WO PCT/EP2010/064348 patent/WO2011039176A1/en active Application Filing
- 2010-09-28 MX MX2012003612A patent/MX2012003612A/es not_active Application Discontinuation
- 2010-09-28 BR BR112012007109A patent/BR112012007109A2/pt not_active IP Right Cessation
- 2010-09-28 CA CA2775976A patent/CA2775976A1/en not_active Abandoned
- 2010-09-28 RU RU2012117804/10A patent/RU2567660C2/ru not_active IP Right Cessation
- 2010-09-28 EP EP10760993A patent/EP2482829A1/en not_active Withdrawn
- 2010-09-28 US US13/499,535 patent/US20120244125A1/en not_active Abandoned
- 2010-09-28 JP JP2012531354A patent/JP5911424B2/ja not_active Ceased
- 2010-09-28 AU AU2010303020A patent/AU2010303020B2/en not_active Ceased
- 2010-09-28 CN CN2010800437884A patent/CN102665737A/zh active Pending
- 2010-09-28 IN IN2463DEN2012 patent/IN2012DN02463A/en unknown
- 2010-09-28 SG SG10201406169VA patent/SG10201406169VA/en unknown
- 2010-09-30 AR ARP100103572A patent/AR078485A1/es unknown
-
2012
- 2012-03-30 CL CL2012000809A patent/CL2012000809A1/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109069553A (zh) * | 2016-04-14 | 2018-12-21 | 杜邦营养生物科学有限公司 | 用于增加瘦体重的双歧杆菌 |
Also Published As
Publication number | Publication date |
---|---|
JP5911424B2 (ja) | 2016-04-27 |
EP2482829A1 (en) | 2012-08-08 |
IN2012DN02463A (es) | 2015-05-22 |
AU2010303020A1 (en) | 2012-04-19 |
MX2012003612A (es) | 2012-04-19 |
WO2011039176A1 (en) | 2011-04-07 |
US20120244125A1 (en) | 2012-09-27 |
RU2012117804A (ru) | 2013-11-20 |
RU2567660C2 (ru) | 2015-11-10 |
BR112012007109A2 (pt) | 2016-07-05 |
CN102665737A (zh) | 2012-09-12 |
SG10201406169VA (en) | 2014-11-27 |
JP2013506631A (ja) | 2013-02-28 |
CL2012000809A1 (es) | 2012-07-13 |
AU2010303020B2 (en) | 2014-11-20 |
CA2775976A1 (en) | 2011-04-07 |
EP2308499A1 (en) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR078485A1 (es) | Bifidobacterium longum atcc baa-999 (bl999) y control de peso | |
AR067906A1 (es) | Lactobacillus rhamnosus y control del peso | |
Sekhon et al. | Prebiotics, probiotics and synbiotics: an overview. | |
AU2010311325B2 (en) | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof | |
RU2012111253A (ru) | Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта | |
AR067971A1 (es) | Uso de composicion para la prevencion y/o tratamiento de desordenes metabolicos | |
AR076862A1 (es) | Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos | |
Tomar et al. | Role of probiotics, prebiotics, synbiotics and postbiotics in inhibition of pathogens | |
WO2012108830A1 (en) | Synbiotic compositions for restoration and reconstitution of gut microbiota | |
BR112019001984A2 (pt) | bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos | |
CN113226062A (zh) | 包含2’-岩藻糖基乳糖(2’fl)以改善胃肠屏障的营养组合物 | |
BR112016018283A2 (pt) | Composição que compreende bifidobacterium animalis ssp. lactis | |
CL2008000928A1 (es) | Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. | |
MX337667B (es) | Combinacion simbiotica para mejorar la microbiota intestinal. | |
BR112013004194A2 (pt) | produto simbiótico | |
ATE463558T1 (de) | Beta-galactosidase mit transgalactosylierungsaktivität | |
Peng et al. | Polyphenols and tri-terpenoids from Olea europaea L. in alleviation of enteric pathogen infections through limiting bacterial virulence and attenuating inflammation | |
RU2018139655A (ru) | Бифидобактерии для увеличения безжировой массы тела | |
Erginkaya et al. | Potential biotherapeutic properties of lactic acid bacteria in foods | |
RU2018145729A (ru) | Композиции и способы для маленьких животных из семейства собачьих | |
RU2018139656A (ru) | Бифидобактерии для снижения потребления пищи, энергии и/или жиров | |
Yu et al. | Mucin2 is Required for Probiotic Agents-Mediated Blocking Effects on Meningitic E. coli-Induced Pathogenicities S | |
Ho et al. | Effects of supplementation of citrulline and Lactobacillus helveticus ASCC 511 on intestinal epithelial cell integrity | |
JP2015533484A5 (es) | ||
KR20240037256A (ko) | 생리학적으로 허용되는 효모 조성물 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |